skip to primary navigationskip to content

Cambridge Service Alliance

At the forefront of service transformation in the digital era

Studying at Cambridge

 

Ecosystems Evolution Enabled by Technology

Ecosystem evolution enabled by technology – an example in Healthcare

Healthcare is changing – fast

The search for new business models for the Pharmaceutical industry is being driven by a number of factors:

  1. Society’s healthcare burden is growing due to populations that are living longer (and being unwell for longer)
  2. Payors want to now pay for outcomes from medicines not just for the pills
  3. Generics (launched after patent expiry) are cutting the value of established brands and markets
  4. Pharma R&D is not producing the blockbusters companies have needed to support their revenues
  5. Pharmaceutical companies are looking to switch roles from being pure manufacturers to service providers delivering outcomes

 

Is personalised medicine finally here?

IBM’s Smarter Planet concept – that increasing instrumentation and interconnections are making the world more intelligent – shows that by connecting healthcare devices such as pill dispensers, and health monitoring devices (e.g. glucose meters, etc), insight can be gained to health at the individual, and population scale.

Such insight would benefit multiple stakeholders in the healthcare ecosystem:

Patients quantify their health outcomes, and Carers receive support through reminders. 
Healthcare providers gain insight to patient health, from which to recommend appropriate interventions.  Payors benefit from lower healthcare costs and focus on patient outcomes

New players are going to change the health ecosystem

The large-scale, long-term deployment of this approach, based on an extensive collaboration between healthcare and technology could deliver:

  1. Novel analytical techniques enabling patients, HCPs, and other stakeholders to act quickly 
  2. Accelerated incorporation of analytics using advanced, predictive capabilities for pattern and context recognition into health assessment
  3. Value-based pricing for medicines based on pseudo real-time health outcomes data that will radically alter the way in which medicines are developed and priced by the pharmaceutical industry.

Contact: Amer Fasihi

Filed under: , ,

RSS Feed Latest news

'Using AI to Track How Customers Feel — In Real Time' published in the Harvard Business Review

May 13, 2021

The paper 'Using AI to Track How Customers Feel — In Real Time' by Mohamed Zaki, Janet R. McColl-Kennedy and Andy Neely has been published in Harvard Business Review.

Industry Day 2020 | What we learnt

Dec 06, 2020

What is the future of services in the new pandemic-driven era? This was the topic explored at our 2020 Industry Day by senior executives from L'Oréal, Microsoft Research, Manchester United and start-up, Fairjungle.

Understanding business models in the construction sector

Nov 25, 2020

What’s standing in the way of offsite manufacturing? For decades, the construction sector has been hailing it as the next big thing but we have yet to see it really taking off. Why is that, when the technologies and processes already exist? Dr Zakaria Dakhli believes it is due to a fundamental incompatibility between business models and it is only when this has been fully understood that the long-awaited transformation can take place.

A machine learning approach to quality control

Nov 14, 2020

Most of the products we take for granted contain huge numbers of components assembled in multiple stages by different manufacturers. Quality control is vital throughout the assembly process with rigorous testing required at every step.

Digital twins: driving business model innovation

Nov 06, 2020

For B2B firms struggling to reap the rewards of digitalisation, could digital twins be the way forward? In this article, CSA's Dr Erika Pärn and colleagues from the Fraunhofer Institute and Technische Universität in Dortmund, explore the relationship between this emerging technology and business model innovation.

View all news